Gasdermin E in glioblastoma -pyroptosis resistance and tumor-promoting functions.
Ontology highlight
ABSTRACT: Treatment of glioblastoma (GB), the most common and most aggressive malignant brain tumor, has made little progress over the past two decades. Despite extensive research on apoptosis and autophagy, necrotic cell death mechanisms like pyroptosis, which have the potential to stimulate anti-tumor immune responses, remain largely underexplored in GB. Here, we investigated whether Gasdermin E (GSDME)-mediated pyroptosis can be induced in GB by employing the drug raptinal, an inducer of cytochrome c release. Using human patient-derived and mouse GB cell lines, we showed that raptinal promotes GSMDE cleavage. However, although a strong pyroptotic response was observed in mouse cell lines, it was weak in human cell lines. This resistance was partially reversed by the calcium chelator BAPTA-AM, ind
SUBMITTER: Solel E
PROVIDER: S-EPMC12182582 | biostudies-literature | 2025 Jun
REPOSITORIES: biostudies-literature
ACCESS DATA